Catheter Precision becomes Flyte Aviation; 1-for-10 reverse split, ticker VJET, ~2.1M shares out

Catheter Precision, Inc.

Name change to Flyte Aviation, Inc. and 1-for-10 reverse split effective Oct 5, 2026; about 2,101,987 shares outstanding; new CUSIP 74933X 807.
Ticker switched to VJET on NYSE American (from VTAK), trading on a split-adjusted basis at the open on Oct 5, 2026.
Rebranding targets the $11.6B US private jet charter market, ~6.9% CAGR, projected to exceed $14B by 2029 and $16B by 2031 (Fortune Business Insights, Sept 14, 2026).
Founder Marc Sellouk (Flyte founded 2018) and CEO David Jenkins tout an AI-driven digital booking platform; Q4 2026 spend planned on website, mobile app, marketing and AI analytics.
Named 'Official Air Travel Partner' of the 34th Hamptons International Film Festival, Oct 2-12, 2026; Life Sciences ops (LockeT, VIVO) to continue and not be downsized.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.